Title: 5-Days-After-Sex Pill Gets FDA Panel Nod
Category: Health News
Created: 6/18/2010 9:10:00 AM
Last Editorial Review: 6/18/2010 9:10:28 AM

Further information:

Article source

Related posts:

1. Panel Critical of FDA’s Asthma Drug Ruling
2. Vivus’s Qnexa Gets Thumbs Down From Mixed FDA Panel
3. FDA Acknowledges Need for Daily Multiple Sclerosis Pill by Granting Fingolimod Priority Review Status
4. Pill Kills Hard-to-Treat Head Lice
5. Panel Finds Many Women Can Avoid Repeat C-Sections